These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6838618)

  • 1. Failure of 2 Hydroxyestradiol to interact with dopamine inhibition of human prolactin secretion in vitro and with dopamine receptors of prolactin-secreting adenomas.
    Peillon F; Brandi AM; Bression D; Le Dafniet M; Racadot J
    Biochem Biophys Res Commun; 1983 Apr; 112(1):42-6. PubMed ID: 6838618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of dopamine receptors in human growth hormone (GH)-secreting adenomas with concomitant study of dopamine inhibition of GH secretion in a perifusion system.
    Bression D; Brandi AM; Nousbaum A; Le Dafniet M; Racadot J; Peillon F
    J Clin Endocrinol Metab; 1982 Sep; 55(3):589-93. PubMed ID: 7096541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of dopamine and alpha-adrenergic receptors in human prolactin-secreting adenomas with [3H]-dihydroergocryptine.
    Ramsdell JS; Bethea CL; Jaffe RB; Wilson CB; Weiner RI
    Neuroendocrinology; 1985 Jun; 40(6):518-25. PubMed ID: 2861582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Demonstration of dopaminergic receptors in human pituitary adenomas secreting prolactin].
    Bression D; Martres MP; Peillon F
    C R Seances Acad Sci D; 1979 Jul; 289(2):133-5. PubMed ID: 117916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic receptors in human prolactin-secreting adenomas: a quantitative study.
    Bression D; Brandi AM; Martres MP; Nousbaum A; Cesselin F; Racadot J; Peillon F
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1037-44. PubMed ID: 7419680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.
    De Camilli P; Macconi D; Spada A
    Nature; 1979 Mar; 278(5701):252-4. PubMed ID: 423973
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct effect of estradiol on the number of dopamine receptors in the anterior pituitary of ovariectomized rats.
    Pasqualini C; Bojda F; Kerdelhué B
    Endocrinology; 1986 Dec; 119(6):2484-9. PubMed ID: 3780536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex steroids interact with dopamine at the hypothalamic and pituitary levels to modulate prolactin secretion.
    Labrie F; Ferland L; Denizeau F; Beaulieu M
    J Steroid Biochem; 1980 Jan; 12():323-30. PubMed ID: 7421220
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopaminergic binding sites in human pituitary adenomas other than prolactinomas.
    Serri O; Marchisio AM; Collu R; Hardy J; Somma M
    Horm Res; 1984; 19(2):97-102. PubMed ID: 6706294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antagonistic regulation by estradiol and progesterone of the rat pituitary domperidone binding sites: correlation with ovarian steroid regulation of the dopaminergic inhibition of prolactin secretion in vitro.
    Bression D; Brandi AM; Pagesy P; Le Dafniet M; Martinet M; Brailly S; Michard M; Peillon F
    Endocrinology; 1985 May; 116(5):1905-11. PubMed ID: 3987624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of high affinity dopamine receptors in estrone-induced, prolactin-secreting rat pituitary adenomas: a model for human prolactinomas.
    Eljarmak D; Marchisio AM; Lis M; Collu R
    Horm Res; 1985; 21(2):107-16. PubMed ID: 3920132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pimozide and domperidone administration on prolactin levels in neonatally estrogenized female rats.
    Aguilar E; López F; Pinilla L; Bellido C; Vaticón MD
    Rev Esp Fisiol; 1985 Jun; 41(2):183-6. PubMed ID: 4041067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of different Ca2+ entry blockers on dopamine-induced inhibition of in vitro prolactin secretion.
    Di Renzo G; Amoroso S; Maida P; Canzoniero L; Nappi C; Taglialatela M; Annunzia L
    Eur J Pharmacol; 1988 Feb; 146(2-3):201-6. PubMed ID: 3371396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adrenalectomy and dexamethasone treatment on prolactin secretion of lactating rats.
    Horváth KM; Bánky Z; Tóth BE; Halász B; Nagy GM
    Brain Res Bull; 2001 Dec; 56(6):589-92. PubMed ID: 11786246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
    Lévesque D; Di Paolo T
    Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrabenazine has properties of a dopamine receptor antagonist.
    Login IS; Cronin MJ; MacLeod RM
    Ann Neurol; 1982 Sep; 12(3):257-62. PubMed ID: 7137960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]Spiperone binding to human anterior pituitaries and pituitary adenomas secreting prolactin, growth hormone, and adrenocorticotropic hormone.
    Cronin MJ; Cheung CY; Wilson CB; Jaffe RB; Weiner RI
    J Clin Endocrinol Metab; 1980 Feb; 50(2):387-91. PubMed ID: 6243670
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine receptors on dispersed bovine anterior pituitary cells.
    Ramsdell JS; Monnet F; Weiner RI
    Neuroendocrinology; 1985 Aug; 41(2):169-76. PubMed ID: 3900789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pituitary dopamine receptor.
    Labrie F; Di Paolo T; Raymond V; Ferland L; Beaulieu M
    Adv Biochem Psychopharmacol; 1980; 23():217-27. PubMed ID: 6104906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.